Form 4: Modular Medical Director Carmen Volkart Reports Stock Transactions
SEC Form 4 Filing
Director Carmen Volkart reports acquisition and disposal of Modular Medical, Inc. common stock and acquisition of options.
Summary
- On March 29, 2024, Carmen Volkart, a director of Modular Medical, Inc., acquired 625 shares of common stock.
- These shares were issued in accordance with the company's Outside Director Compensation Plan.
- On the same day, Volkart disposed of 625 shares of common stock.
- Following these transactions, Volkart beneficially owns 9,585 shares of common stock.
- On March 31, 2024, Volkart acquired an option to purchase 7,500 shares of common stock at an exercise price of $1.95, which was fully vested and exercisable on the grant date and expires on March 31, 2034.
- The option was granted in accordance with the Issuer's Outside Director Compensation Plan.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of insider trading activity. The option grant could be seen as slightly positive, but it's not a major event.
Positives
- The acquisition of options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings to gain insights into management's perspective on the company's stock.
Stakeholder Impact
- Shareholders may be interested in the director's transactions as an indicator of confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 03/29/2024 | Acquisition and disposal of common stock |
| 03/31/2024 | Grant date and exercisable date for stock options |
| 03/31/2034 | Expiration date for stock options |
| 04/02/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.